ReviewOpen life sciences2025
Exploring the toxicity mechanisms and detoxification methods of Rhizoma Paridis.
Review in Open life sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although there has been research on the toxicity of Rhizoma Paridis (Chong Lou), a systematic and comprehensive evaluation, as well as targeted strategies for mitigating its toxicity, remains lacking. This review aims to provide a thorough assessment of the toxicological properties of Rhizoma Paridis, offering reliable guidance for its safe application. The article focuses on the toxicity and underlying mechanisms of Rhizoma Paridis and reviews the applications of both traditional Chinese medicine and modern scientific technologies in detoxification. Finally, it proposes future research directions, emphasizing the need for further exploration of chronic toxicity mechanisms and advocating for the integration of traditional and modern detoxification methods to ensure the safe clinical use of Rhizoma Paridis. This review provides the latest theoretical foundation for the safe use and further development of Rhizoma Paridis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.